Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?”

Boerma R.S., Braun K.P., van den Broek M.P., van Berkestijn F.M., Swinkels M.E., Hagebeuk E.O. et al.:Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach. Neurotherapeutics, 2015, Aug. 22. [Epub ahead of print].10.1007/s13311-015-0386-2472066926297079Search in Google Scholar

Zhang B., McDaniel S.S., Rensing N.R., Wong M.:Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One, 2013, 8: e57445.10.1371/journal.pone.0057445357771023437388Search in Google Scholar

Lingua:: Inglese

Frequenza di pubblicazione:: 2 volte all'anno
Argomenti della rivista:: Medicina, Medicina clinica, Medicina clinica, altro, Neurologia, Farmacologia, Tossicologia, Farmacia, Farmaceutica clinica

Feed RSS della rivista

Comments to “Is epileptogenesis a key to treatment of childhood epileptic encephalopathies?”

Elena Belousova

Pubblicato online: 24 nov 2015

Pagine: 89 - 90

Ricevuto: 12 nov 2015

Accettato: 24 nov 2015

DOI: https://doi.org/10.21307/joepi-2015-0028

Parole chiave

© 2015 Elena Belousova et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.